Sanjiv Patel - Apr 12, 2022 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
President and CEO, Director
Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Apr 12, 2022
Transactions value $
-$2,267,440
Form type
4
Date filed
4/14/2022, 09:20 PM
Previous filing
Jan 31, 2022
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Options Exercise $115K +28K +11.03% $4.12 282K Apr 12, 2022 Direct F1
transaction RLAY Common Stock Sale -$890K -28K -9.94% $31.80 254K Apr 12, 2022 Direct F1, F2
transaction RLAY Common Stock Options Exercise $57.7K +14K +5.52% $4.12 268K Apr 13, 2022 Direct F1
transaction RLAY Common Stock Sale -$447K -14K -5.23% $31.96 254K Apr 13, 2022 Direct F1, F3
transaction RLAY Common Stock Options Exercise $70.6K +14K +5.52% $5.04 268K Apr 13, 2022 Direct F1
transaction RLAY Common Stock Sale -$447K -14K -5.23% $31.94 254K Apr 13, 2022 Direct F1, F4
transaction RLAY Common Stock Options Exercise $57.7K +14K +5.52% $4.12 268K Apr 14, 2022 Direct F1
transaction RLAY Common Stock Sale -$427K -14K -5.23% $30.51 254K Apr 14, 2022 Direct F1, F5
transaction RLAY Common Stock Options Exercise $70.6K +14K +5.52% $5.04 268K Apr 14, 2022 Direct F1
transaction RLAY Common Stock Sale -$427K -14K -5.23% $30.51 254K Apr 14, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLAY Stock Option (Right to Buy) Options Exercise $0 -28K -16.26% $0.00 144K Apr 12, 2022 Common Stock 28K $4.12 Direct F1, F6
transaction RLAY Stock Option (Right to Buy) Options Exercise $0 -14K -9.71% $0.00 130K Apr 13, 2022 Common Stock 14K $4.12 Direct F1, F6
transaction RLAY Stock Option (Right to Buy) Options Exercise $0 -14K -1.91% $0.00 719K Apr 13, 2022 Common Stock 14K $5.04 Direct F1, F7
transaction RLAY Stock Option (Right to Buy) Options Exercise $0 -14K -10.75% $0.00 116K Apr 14, 2022 Common Stock 14K $4.12 Direct F1, F6
transaction RLAY Stock Option (Right to Buy) Options Exercise $0 -14K -1.95% $0.00 705K Apr 14, 2022 Common Stock 14K $5.04 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $30.89 to $32.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 This transaction was executed in multiple trades at prices ranging from $31.48 to $32.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 This transaction was executed in multiple trades at prices ranging from $31.43 to $32.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 This transaction was executed in multiple trades at prices ranging from $30.00 to $32.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6 The shares underlying this option shall vest in sixteen (16) equal quarterly installments after March 23, 2018, subject to the reporting person's continued employment through each applicable vesting date.
F7 The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date.